Cargando…
Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317036/ https://www.ncbi.nlm.nih.gov/pubmed/37395727 http://dx.doi.org/10.18632/oncotarget.28471 |
| _version_ | 1785067829660221440 |
|---|---|
| author | Teixidor, Eduard Sais, Elia Vásquez, Carmen Amalia Carbajal, Walter Hernández, Alejandro Sánchez, Gloria Izquierdo, Angel Verdura, Sara Menéndez, Javier A. Bosch-Barrera, Joaquim |
| author_facet | Teixidor, Eduard Sais, Elia Vásquez, Carmen Amalia Carbajal, Walter Hernández, Alejandro Sánchez, Gloria Izquierdo, Angel Verdura, Sara Menéndez, Javier A. Bosch-Barrera, Joaquim |
| author_sort | Teixidor, Eduard |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10317036 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103170362023-07-04 Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma Teixidor, Eduard Sais, Elia Vásquez, Carmen Amalia Carbajal, Walter Hernández, Alejandro Sánchez, Gloria Izquierdo, Angel Verdura, Sara Menéndez, Javier A. Bosch-Barrera, Joaquim Oncotarget Addendum Impact Journals LLC 2023-07-01 /pmc/articles/PMC10317036/ /pubmed/37395727 http://dx.doi.org/10.18632/oncotarget.28471 Text en Copyright: © 2023 Teixidor et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Addendum Teixidor, Eduard Sais, Elia Vásquez, Carmen Amalia Carbajal, Walter Hernández, Alejandro Sánchez, Gloria Izquierdo, Angel Verdura, Sara Menéndez, Javier A. Bosch-Barrera, Joaquim Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma |
| title | Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma |
| title_full | Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma |
| title_fullStr | Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma |
| title_full_unstemmed | Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma |
| title_short | Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma |
| title_sort | addendum: immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high pd-l1 expressing lung adenocarcinoma |
| topic | Addendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317036/ https://www.ncbi.nlm.nih.gov/pubmed/37395727 http://dx.doi.org/10.18632/oncotarget.28471 |
| work_keys_str_mv | AT teixidoreduard addendumimmunerelatedadverseeventsandatypicalradiologicalresponsewithcheckpointinhibitorimmunotherapyinanelderlypatientwithhighpdl1expressinglungadenocarcinoma AT saiselia addendumimmunerelatedadverseeventsandatypicalradiologicalresponsewithcheckpointinhibitorimmunotherapyinanelderlypatientwithhighpdl1expressinglungadenocarcinoma AT vasquezcarmenamalia addendumimmunerelatedadverseeventsandatypicalradiologicalresponsewithcheckpointinhibitorimmunotherapyinanelderlypatientwithhighpdl1expressinglungadenocarcinoma AT carbajalwalter addendumimmunerelatedadverseeventsandatypicalradiologicalresponsewithcheckpointinhibitorimmunotherapyinanelderlypatientwithhighpdl1expressinglungadenocarcinoma AT hernandezalejandro addendumimmunerelatedadverseeventsandatypicalradiologicalresponsewithcheckpointinhibitorimmunotherapyinanelderlypatientwithhighpdl1expressinglungadenocarcinoma AT sanchezgloria addendumimmunerelatedadverseeventsandatypicalradiologicalresponsewithcheckpointinhibitorimmunotherapyinanelderlypatientwithhighpdl1expressinglungadenocarcinoma AT izquierdoangel addendumimmunerelatedadverseeventsandatypicalradiologicalresponsewithcheckpointinhibitorimmunotherapyinanelderlypatientwithhighpdl1expressinglungadenocarcinoma AT verdurasara addendumimmunerelatedadverseeventsandatypicalradiologicalresponsewithcheckpointinhibitorimmunotherapyinanelderlypatientwithhighpdl1expressinglungadenocarcinoma AT menendezjaviera addendumimmunerelatedadverseeventsandatypicalradiologicalresponsewithcheckpointinhibitorimmunotherapyinanelderlypatientwithhighpdl1expressinglungadenocarcinoma AT boschbarrerajoaquim addendumimmunerelatedadverseeventsandatypicalradiologicalresponsewithcheckpointinhibitorimmunotherapyinanelderlypatientwithhighpdl1expressinglungadenocarcinoma |